Antibiotic Bootcamps for Developers: Understanding the Potential for Antimicrobial Resistance in the Drug Discovery Process
ASM/ESCMID Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
3-6 September 2019, Boston
Collaboratively organized by GARDP, CARB-X, REPAIR Impact Fund, JPIMAR and Wellcome Trust
Moderator: Ursula Theuretzbacher (Center for Anti-Infective Agents, Austria)
Speakers: Michael Mourez (Evotec, France), Douglas Huseby (University Uppsala, Sweden)
Q&A session: Michael Mourez (Evotec, France), Douglas Huseby (University Uppsala, Sweden), Mariana Castanheira (JMI Laboratories, U.S.), Ursula Theuretzbacher (Center for Anti-Infective Agents, Austria)
- Introductions (John H. Rex & Ursula Theuretzbacher)
- Testing for the Potential of Emergence of Resistance (Michael Mourez))
- Improving Predictions of the Risk of Emergence of Resistance (Douglas Huseby)
- Questions & Answers